Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jul;56(7):1351-62.
doi: 10.1194/jlr.P058032. Epub 2015 May 25.

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity

Affiliations

PLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activity

Daniel Seung Kim et al. J Lipid Res. 2015 Jul.

Abstract

Recent studies have failed to demonstrate a causal cardioprotective effect of HDL cholesterol levels, shifting focus to the functional aspects of HDL. Phospholipid transfer protein (PLTP) is an HDL-associated protein involved in reverse cholesterol transport. This study sought to determine the genetic and nongenetic predictors of plasma PLTP activity (PLTPa), and separately, to determine whether PLTPa predicted carotid artery disease (CAAD). PLTPa was measured in 1,115 European ancestry participants from a case-control study of CAAD. A multivariate logistic regression model was used to elucidate the relationship between PLTPa and CAAD. Separately, a stepwise linear regression determined the nongenetic clinical and laboratory characteristics that best predicted PLTPa. A final stepwise regression considering both nongenetic and genetic variables identified the combination of covariates that explained maximal PLTPa variance. PLTPa was significantly associated with CAAD (7.90 × 10(-9)), with a 9% decrease in odds of CAAD per 1 unit increase in PLTPa (odds ratio = 0.91). Triglyceride levels (P = 0.0042), diabetes (P = 7.28 × 10(-5)), paraoxonase 1 (PON1) activity (P = 0.019), statin use (P = 0.026), PLTP SNP rs4810479 (P = 6.38 × 10(-7)), and PCIF1 SNP rs181914932 (P = 0.041) were all significantly associated with PLTPa. PLTPa is significantly inversely correlated with CAAD. Furthermore, we report a novel association between PLTPa and PON1 activity, a known predictor of CAAD.

Keywords: coronary artery disease; paraoxonase 1; phospholipid transfer protein.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Correlation between PLTPa measurements from the gold-standard radiometric liposome assay used in the current study and the widely used commercial fluorometric liposome assay. The black line represents the correlation coefficient from a classical linear regression model between the two PLTPa assays.
Fig. 2.
Fig. 2.
OR association with CAAD status of PLTPa and predictors from multivariate logistic regression (n = 1,056). *0.05 > P > 0.001. **P < 0.001. See supplementary Table 4 for full regression model coefficients.

References

    1. Rosenson R. S. 2005. Low HDL-C: a secondary target of dyslipidemia therapy. Am. J. Med. 118: 1067–1077. - PubMed
    1. Castelli W. P. 1983. Cardiovascular disease and multifactorial risk: challenge of the 1980s. Am. Heart J. 106: 1191–1200. - PubMed
    1. Acharjee S., Boden W. E., Hartigan P. M., Teo K. K., Maron D. J., Sedlis S. P., Kostuk W., Spertus J. A., Dada M., Chaitman B. R., et al. 2013. Low levels of high-density lipoprotein cholesterol and increased risk of cardiovascular events in stable ischemic heart disease patients: a post-hoc analysis from the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation). J. Am. Coll. Cardiol. 62: 1826–1833. - PMC - PubMed
    1. Boden W. E., Probstfield J. L., Anderson T., Chaitman B. R., Desvignes-Nickens P., Koprowicz K., McBride R., Teo K., Weintraub W.; AIM-HIGH Investigators. 2011. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N. Engl. J. Med. 365: 2255–2267. - PubMed
    1. Voight B. F., Peloso G. M., Orho-Melander M., Frikke-Schmidt R., Barbalic M., Jensen M. K., Hindy G., Hólm H., Ding E. L., Johnson T., et al. 2012. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet. 380: 572–580. - PMC - PubMed

Publication types